Ross Medical Technology receives FDA 510(k) clearance for ECG monitoring platform

New control center platform and device offers continuous real-time ECG monitoring and cardiac event detection for patients receiving a hospital like workup.

Online PR News – 24-March-2015 – Saddle River, New Jersey – ROSS MEDICAL TECHNOLOGY, Inc. is pleased to announce that its newest medical device and related system, CardiacLinx, has received 510(k) clearance from the U.S. Food and Drug Administration. Ross Medical Technology is the Leader in developing technology for ePatient Care, replacing traditional in-patient hospital admissions.

CardiacLinx is a multipurpose control center and device platform designed for remote management of patients. The ambulatory device may be used in physician's offices, hospitals or rehabilitation facilities, the patient’s home, or similar use areas with remote clinician analysis.

CardiacLinx continuously transmits all of the patient’s electrocardiograph (ECG) signal to a central control center using cellular technology. The platform allows for the real time continuous evaluation of arrhythmias, ischemic attacks, and other events on a large scale patient base. Embedded algorithms provide automatic interpretations to assist the medical professional in their clinical decision making.

For further information, please visit and